Status:
COMPLETED
The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Contrast-induced Acute Kidney Injury
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to assess the role of statins and different dosage regimens in the prevention of contrast-induced acute kidney injury in patients with cardiovascular diseases requiring intrave...
Eligibility Criteria
Inclusion
- Written informed consent
- Indications for computer tomography with intravenous contrast media administration
- Cardiovascular diseases (arterial hypertension, arrhythmia etc)
Exclusion
- Pregnancy
- Statin therapy before inclusion in the study
- Acute coronary syndromes
- Contraindications for statins administration
- Patients with chronic kidney disease stages 4-5
- Contraindications for computer tomography with contrast media administration
- Nephrotoxic drugs use (NSAIDS, vancomycin etc)
Key Trial Info
Start Date :
October 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04666389
Start Date
October 15 2020
End Date
January 10 2023
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sechenov University
Moscow, Russia